Systemic and Local Mucosal Immune Responses Were Induced by HIV-1CN54 DNA Vaccine Intranasally Administered into Mice and then Boosted with Recombinant Vaccina Virus

张欣,陈磊,陶欣,肖瑶,杨贵波,邵一鸣

DOI: https://doi.org/10.3969/j.issn.1000-8861.2003.06.003

2003-01-01

Abstract:Objective To study whether recombinant Vaccina Virus syngp120 (rVVsyngp120) or mCN54gp120 (rVVmCN54gp120) candidate vaccine enhanced the immunogenity of syngp120 DNA vaccine intranasally administered into mice.Methods After DNA vaccine was administered into mice on 0, 7, 14, 21 d, rVVsyngp120 or rVVmCN54gp120 candidate vaccine was then intranasally administered into mice on 28, 35, 42 d. Detect spleen and MLN lymphocyte proliferation and CD8 +CTL response in vitro. Collection of serum and mucosal washes to detect antigen specific IgG and IgA antibody levels, and investigate whether it can neutralize HIV-1 SF33 strain.Results After single DNA immunization, spleen and MLN lymphocyte proliferation and CTL response were induced. Meanwhile, antigen specific IgG in serum and IgA in mucosal washes were also elicited.On 56 d, findings demonstrated that both MLN lymphocyte proliferation response and MLN and spleen CTL response were enhanced by rVVmCN54gp120. But MLN CTL response was enhanced by rVVsyngp120. Serum IgG antibody titer was weakly increased, but mucosal (including fecal and vaginal washes) IgA levels were not increased. Antigen specific IgA in serum or IgG in mucosal washes was hardly detected. It is serum but not vaginal washes can neutralize HIV-1 SF33.Conclusions Single DNA vaccine intranasally immunized induced weak systemic and mucosal immune responses (humoral and cellular), but kept in short time. rVVmCN54gp120 and rVVsyngp120 candidate vaccine mainly enhanced local mucosal cellular immune responses. Antigen specific IgG level in serum was weakly increased,while antigen specific IgA level in mucosal washes were not improved.